IGF1 and Alzheimer disease: have confirmed the presence of resistance to IGF-I receptor signaling by demonstrating that in the post-mortem AD brain, the signaling responses to IGF-1 in the IGF-IR/PI3K/AKT/mTOR pathway are strongly attenuated (160).